EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 11-Jul-2025 23:11 ET (12-Jul-2025 03:11 GMT/UTC)

13-May-2025

Nanoparticles revolutionize breast cancer diagnosis and treatment: A leap forward in oncology research

Sichuan International Medical Exchange and Promotion Association
Peer-Reviewed Publication

A review in MedComm–Biomaterials and Applications highlights how nanoparticles are revolutionizing breast cancer diagnosis and treatment. These advanced nanomaterials enhance early detection, reduce side effects, and combat drug resistance, offering promising solutions for aggressive subtypes like triple-negative breast cancer.

Journal: MedComm – Biomaterials and Applications

13-May-2025

World-first discovery of FLASH effect conditions using compact carbon ion synchrotron opens door to safer cancer therapy

The University of Osaka
Peer-Reviewed Publication

A research team from The University of Osaka has made a significant breakthrough in cancer radiotherapy by identifying conditions under which carbon ion beams—delivered at ultra-high dose rates (uHDR)—can protect normal cells. This phenomenon, known as the “FLASH effect,” could revolutionize cancer treatment by reducing side effects and improving patients’ quality of life.

Journal: Anticancer Research
Funder: Japan Society for the Promotion of Science, Joint research agreement among Osaka University, Hitachi High‐Tech Corporation, Osaka Heavy Ion Therapy Center, Osaka Heavy Ion Administration Company, Hyogo Medical University

13-May-2025

First-ever long read datasets added to two Kids First studies

Gabriella Miller Kids First Data Resource Center
Peer-Reviewed Publication

This new Kids First data creates a fuller understanding of how genetics contributes to childhood cancers and congenital disorders, opening additional doors for prevention and treatment.

13-May-2025

Fragmented care does not affect survival outcomes for retroperitoneal sarcoma, Fox Chase Cancer Center study finds

Temple University Health System
Peer-Reviewed Publication

In a study recently published by researchers at Fox Chase Cancer Center, patients being treated for retroperitoneal sarcoma at multiple facilities experienced longer delays between diagnosis and treatment and traveled farther to receive treatment, but their overall survival rates were equivalent to patients receiving nonfragmented care.

Journal: The American Journal of Surgery

13-May-2025

New approach to treating aggressive breast cancers shows significant improvement in survival

University of Cambridge
Peer-Reviewed Publication

A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. In a trial where cancers were treated with chemotherapy followed by a targeted cancer drug before surgery, 100% of patients survived the critical three-year period post-surgery.

Journal: Nature Communications
Funder: Cancer Research UK, AstraZeneca, NIHR Cambridge Biomedical Research Centre, Addenbrooke's Charitable Trust

13-May-2025

Researchers identify texture patterns associated with breast cancer risk

Radiological Society of North America
Peer-Reviewed Publication

In one of the larger studies of its kind, researchers have identified six breast texture patterns that may be associated with increased cancer risk, according to a new study.

Journal: Radiology

13-May-2025

New insights into x-ray sterilization: Dose rate matters

Nagoya City University
Peer-Reviewed Publication

Scientists investigate the inactivation efficacy of X-ray and assess the effective management of X-ray sterilization.

Journal: Scientific Reports
Funder: JPSJ KAKENHI

13-May-2025

Pediatric Investigation study identifies immune drivers of medulloblastoma metastasis using explainable AI

Pediatric Investigation
Peer-Reviewed Publication

Medulloblastoma is the most common malignant pediatric brain tumor with a high risk of metastasis and poor survival outcomes. To delineate the metastatic microenvironment, researchers in China have developed an explainable machine learning model that identifies key immune cells and cytokine markers linked to tumor dissemination and prognosis. Their model offers a transparent, data-driven approach that could help clinicians better assess risk and personalize treatment for children with this life-threatening disease.

Journal: Pediatric Investigation

13-May-2025

DiffInvex reveals how cancers rewire driver genes to beat chemotherapy

Institute for Research in Biomedicine (IRB Barcelona)
Peer-Reviewed Publication

IRB Barcelona researchers have developed a new computational tool that tracks the evolutionary shifts in selection pressure during tumorigenesis and chemotherapy.

Using more than 8,500 cancer whole-genome sequences, the team identified 11 cancer driver genes linked to chemoresistance to specific anticancer drugs.

The study has been published in the journal Nature Communications.

Journal: Nature Communications

13-May-2025

HKU biologists identify protein DNM1 as key regulator in ovarian cancer metastasis

The University of Hong Kong
Peer-Reviewed Publication

Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because current treatments are not effective once the cancer has spread (metastasised) beyond the ovaries. A recent study led by Professor Alice WONG, Interim Director of the School of Biological Sciences at The University of Hong Kong (HKU), has identified a critical factor driving this metastasis, offering promising new directions for targeted treatment strategies. The team’s findings have just been published in Protein and Cell and featured as the journal’s cover article, highlighting the significance of their work.

Journal: Protein & Cell